JP6506746B2 - ステアリドン酸及びオリーブ油を含む食用の脂質組成物 - Google Patents

ステアリドン酸及びオリーブ油を含む食用の脂質組成物 Download PDF

Info

Publication number
JP6506746B2
JP6506746B2 JP2016521617A JP2016521617A JP6506746B2 JP 6506746 B2 JP6506746 B2 JP 6506746B2 JP 2016521617 A JP2016521617 A JP 2016521617A JP 2016521617 A JP2016521617 A JP 2016521617A JP 6506746 B2 JP6506746 B2 JP 6506746B2
Authority
JP
Japan
Prior art keywords
sda
lipid composition
oil
olive oil
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016521617A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533716A (ja
Inventor
ホフストラ，ハルメン
サエレ，オリヤン
エイデ，オラ
クリスティーネ サガ，リンダ
クリスティーネ サガ，リンダ
Original Assignee
ジンジノ アーベー
ジンジノ アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジンジノ アーベー, ジンジノ アーベー filed Critical ジンジノ アーベー
Publication of JP2016533716A publication Critical patent/JP2016533716A/ja
Application granted granted Critical
Publication of JP6506746B2 publication Critical patent/JP6506746B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
JP2016521617A 2013-10-07 2014-10-07 ステアリドン酸及びオリーブ油を含む食用の脂質組成物 Active JP6506746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13187560 2013-10-07
EP13187560.1 2013-10-07
PCT/EP2014/071418 WO2015052171A1 (en) 2013-10-07 2014-10-07 Edible lipid composition comprising stearidonic acid and olive oil

Publications (2)

Publication Number Publication Date
JP2016533716A JP2016533716A (ja) 2016-11-04
JP6506746B2 true JP6506746B2 (ja) 2019-04-24

Family

ID=49301375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521617A Active JP6506746B2 (ja) 2013-10-07 2014-10-07 ステアリドン酸及びオリーブ油を含む食用の脂質組成物

Country Status (15)

Country Link
US (1) US20160227808A1 (enExample)
EP (1) EP3054777B1 (enExample)
JP (1) JP6506746B2 (enExample)
KR (1) KR102373207B1 (enExample)
CN (1) CN105705025B (enExample)
AU (1) AU2014333878B2 (enExample)
CA (1) CA2924265C (enExample)
DK (1) DK3054777T3 (enExample)
EA (1) EA028641B1 (enExample)
ES (1) ES2672313T3 (enExample)
HU (1) HUE037991T2 (enExample)
LT (1) LT3054777T (enExample)
NO (1) NO3054777T3 (enExample)
PL (1) PL3054777T3 (enExample)
WO (1) WO2015052171A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10846257B2 (en) 2014-04-01 2020-11-24 Endance Technology Limited Intelligent load balancing and high speed intelligent network recorders
CN108402466A (zh) * 2017-02-10 2018-08-17 台湾原生药用植物股份有限公司 含不饱和脂肪酸的素食组合物
JP6901274B2 (ja) * 2017-02-14 2021-07-14 株式会社ファンケル ω３系脂肪酸吸収促進用組成物
US11638440B2 (en) * 2017-02-28 2023-05-02 Cg-Bio Genomics, Inc. Healthful supplement food
US20240091110A1 (en) * 2019-10-07 2024-03-21 Colgate-Palmolive Company Oral Care Compositions and Methods of Use
KR102748655B1 (ko) * 2021-12-20 2025-01-02 씨제이제일제당 (주) 스쿠알렌 및 토코페롤을 포함하는 유지의 색가 안정용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150741A1 (en) * 1994-06-17 1995-12-18 Susan Trimbo Pediatric lipid emulsion
ES2202454T3 (es) * 1995-07-04 2004-04-01 Suntory Limited Uso de un agente equilibrante para acidos grasos insaturados omega-3 y omega-6.
JP3466014B2 (ja) * 1995-12-25 2003-11-10 交洋ファインケミカル株式会社 植物性スクワラン濃縮物の製造方法
JP2000104092A (ja) * 1998-09-29 2000-04-11 Nof Corp 血清脂質改善油脂組成物
JP2007056181A (ja) * 2005-08-26 2007-03-08 Toyo Olive Co Ltd 機能性オリーブ油、その製造方法およびその用途
JP4904751B2 (ja) * 2005-09-14 2012-03-28 株式会社カネカ 生体内ｄｈａ合成促進剤
ES2289897B1 (es) * 2005-11-08 2008-12-16 Laboratorios Belmac, S.A. Composicion para administracion transdermica de agentes fisiologicamente activos.
BRPI0708535A2 (pt) * 2006-03-03 2011-05-31 Monsanto Technology Llc meios para melhora da saúde cardiovascular
NZ578166A (en) * 2007-01-03 2012-04-27 Monsanto Technology Llc Food compositions incorporating stearidonic acid
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
EP2448431A4 (en) * 2009-06-30 2014-12-31 Solae Llc BARRIER COMPOSITIONS AND OVEN-COOKED FOOD ENRICHED WITH OMEGA-3 FATTY ACID
FR2948025B1 (fr) * 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3
IN2012DN00563A (enExample) * 2009-07-15 2015-06-12 Solae Llc
US8372465B2 (en) * 2010-02-17 2013-02-12 Bunge Oils, Inc. Oil compositions of stearidonic acid
AU2012100994A4 (en) * 2012-06-30 2012-07-26 Hinson, Brian Mr Hempseed/olive oil and waste blending

Also Published As

Publication number Publication date
EA028641B1 (ru) 2017-12-29
CN105705025B (zh) 2020-06-23
KR102373207B1 (ko) 2022-03-11
EP3054777B1 (en) 2018-03-07
HUE037991T2 (hu) 2018-09-28
PL3054777T3 (pl) 2018-10-31
KR20160065903A (ko) 2016-06-09
CA2924265A1 (en) 2015-04-16
NO3054777T3 (enExample) 2018-08-04
US20160227808A1 (en) 2016-08-11
EA201690692A1 (ru) 2016-07-29
WO2015052171A1 (en) 2015-04-16
LT3054777T (lt) 2018-07-10
CA2924265C (en) 2019-12-24
AU2014333878A2 (en) 2016-04-21
AU2014333878A1 (en) 2016-04-14
CN105705025A (zh) 2016-06-22
AU2014333878B2 (en) 2017-12-07
ES2672313T3 (es) 2018-06-13
DK3054777T3 (en) 2018-06-14
EP3054777A1 (en) 2016-08-17
JP2016533716A (ja) 2016-11-04

Similar Documents

Publication Publication Date Title
Stuchlík et al. Vegetable lipids as components of functional foods
CA2694054C (en) Omega-3 fatty acid fortified composition
CN105705025B (zh) 包含十八碳四烯酸和橄榄油的食用脂质组合物
CA2644154A1 (en) Stearidonic acid for improving cardiovascular health
AU2004210244B2 (en) Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of cholesterol and triglycerides
Vázquez et al. Bioactive lipids
Salsinha et al. Bioactive lipids: Chemistry, biochemistry, and biological properties
Aluko Bioactive lipids
Malik et al. Dietary lipids and health
Ghanbari Shendi Olive oil: Nutraceutical and pharmaceutical food
Zhang et al. Nutritional lipids: an overview of nutritional progress and market trends. J
Kengne et al. Investigation of the antihyperlipidemic property of Raphia hookeri mesocarp oil in high-lard diet (HLD) fed rats
Suroowan et al. Olive and olive oil: a one stop herbal solution for the prophylaxis and management of cardiovascular disorders
HK1227637B (en) Edible lipid composition comprising stearidonic acid and olive oil
HK1227637A1 (en) Edible lipid composition comprising stearidonic acid and olive oil
Koh et al. Role of Virgin Coconut Oil as Multiple Health Promoting Functional Oil
Xu et al. Nutritional lipids: an overview of nutritional progress and market trends
Waly Mediterranean foods and human health
Chandra et al. Health benefits of sesame oil on hypertension and atherosclerosis
Shahidi et al. Dietary Lipid Supplements
Adlouni et al. Th-W53: 3 How to improve atherosclerosis prevention by argan oil?
Bhaskaran et al. Th-W53: 4 Dietary prevention of atherosclerosis in LDL knockout mice: combined effects of components of sesame oil that go beyond plasma lipid lowering
De Pascale et al. Th-W53: 5 The fatty acid composition of chylomicron remnant-like particles influences their effects on macrophage foam cell formation
Lipnik-Stangelj et al. Olive tree-the source of pharmacodynamically active substances
Merzouk Effect of Linseed Oil on Oxidative Stress Parameters and Lipid Profile in Offspring of Obese Rats

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20160914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160914

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170413

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180606

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180904

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190305

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190329

R150 Certificate of patent or registration of utility model

Ref document number: 6506746

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250